Why the study?
Does combination therapy with clopidogrel and aspirin improve platelet inhibition compared to monotherapy in patients with peripheral arterial disease?
Population
20 patients with peripheral arterial disease (PAD)
Comparison
Clopidogrel, aspirin, and then combination… vs Comparisons between clopidogrel monotherapy…
Design
Cohort
Authors
Loading...
Should not yet change antiplatelet practice in PAD; leaves open whether enhanced inhibition improves outcomes in RCTs.
Does combination therapy with clopidogrel and aspirin improve platelet inhibition compared to monotherapy in patients with peripheral arterial disease?
In patients with peripheral arterial disease, combination therapy with clopidogrel and aspirin provides more potent platelet inhibition than either drug alone.
Jagroop et al. (2004) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: